Valeurs | |||||
Le rangement donne un aperçu de toutes les valeurs mobilières classées de manière alphabétique ou selon les indices. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Nom | Code | Analysis date | Cours de clôture | +/- % |
Abrdn Global Premier Properties Fund | AWP | 26. avr 2024 | 3.71 | +1.64 |
Abrdn Healthcare Opportunities Fund Shares Of Beneficial Int | THQ | 26. avr 2024 | 19.28 | +0.47 |
Abrdn Life Sciences Investors Shares Of Beneficial Interest | HQL | 26. avr 2024 | 12.97 | +0.15 |
Abrdn National Municipal Income Fund | VFL | 26. avr 2024 | 9.91 | +0.30 |
Abrdn Total Dynamic Dividend Fund | AOD | 26. avr 2024 | 8.04 | +1.01 |
Abrdn World Healthcare Fund Shares Of Beneficial Interest | THW | 26. avr 2024 | 12.67 | +0.96 |
Absci | ABSI | 26. avr 2024 | 4.58 | +2.81 |
ABVC Biopharma | ABVC | 26. avr 2024 | 1.42 | -10.69 |
Ac Immune SA | ACIU | 26. avr 2024 | 2.35 | +2.62 |
Acacia Research | ACTG | 26. avr 2024 | 4.87 | -0.41 |
Academy Sports and Outdoors | ASO | 26. avr 2024 | 60.72 | +2.79 |
Acadia Healthcare | ACHC | 26. avr 2024 | 73.59 | +0.29 |
Acadia Pharmaceuticals | ACAD | 26. avr 2024 | 16.71 | +2.45 |
Acadia Realty Trust | AKR | 26. avr 2024 | 17.32 | -0.35 |
Acasti Pharma A | ACST | 26. avr 2024 | 2.90 | -0.97 |
Accel Entertainment | ACEL | 26. avr 2024 | 11.19 | -0.97 |
Accelerate Diagnostics | AXDX | 26. avr 2024 | 0.93 | -1.61 |
Accenture A | ACN | 26. avr 2024 | 308.01 | -0.32 |
Acco Brands | ACCO | 26. avr 2024 | 4.83 | -0.41 |
Accolade | ACCD | 26. avr 2024 | 7.89 | -14.15 |
Accuray | ARAY | 26. avr 2024 | 2.19 | +0.46 |
Ace Global Business Acquisition | ACBA | 26. avr 2024 | 12.09 | -0.08 |
Ace Global Business Acquisition Unit | ACBAU | 26. avr 2024 | 11.96 | 0.00 |
Acelyrin | SLRN | 26. avr 2024 | 4.24 | 0.00 |
Achieve Life Sciences | ACHV | 26. avr 2024 | 4.61 | +0.77 |
Achilles Therapeutics ADR | ACHL | 26. avr 2024 | 0.76 | -1.86 |
ACI Worldwide | ACIW | 26. avr 2024 | 33.30 | +1.62 |
Aclarion | ACON | 26. avr 2024 | 0.34 | -14.18 |
Aclaris Therapeutics | ACRS | 26. avr 2024 | 1.20 | +0.84 |
ACM Research A | ACMR | 26. avr 2024 | 27.04 | -4.42 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.